Oncoplastic Breast Reconstruction

What is oncoplastic surgery?

Breast conservation therapy — lumpectomy followed by adjuvant radiation — is a standard treatment for early-stage breast cancer and a strong oncologic option for many patients. The trade-off, when it occurs, is cosmetic: removing breast tissue and irradiating what remains can leave a contour deformity, volume asymmetry, or visible retraction that develops months to years after treatment. Oncoplastic surgery is the discipline that integrates the oncologic operation with reconstructive technique, either to prevent that deformity at the time of lumpectomy or to correct it later.

I practice as a dual board-certified plastic and hand surgeon in Austin, Texas, with academic appointments at Dell Medical School. Breast oncologic reconstruction is a defined part of my clinical practice. The goal of this page is to explain how oncoplastic reconstruction works, when it is performed at the same time as cancer surgery and when it is staged afterward, and how radiation changes both the surgical strategy and the timeline.

When the Breast Surgeon Operates Alone, and When Plastic Surgery Joins the Operation

Breast surgical oncologists frequently perform lumpectomy and oncoplasty independently when the tumor is small relative to the breast, the resection margin is straightforward, and the predicted cosmetic result is acceptable. Standard lumpectomy in that setting is oncologically sound and is the right operation. Plastic surgery is consulted in those cases only if a deformity develops afterward.

Oncoplastic surgery becomes valuable when the predicted defect is large enough to deform the breast — often when the tumor sits in an aesthetically demanding location like the upper inner quadrant, when the resection volume is a meaningful fraction of the breast, or when the patient already has features (large breasts, ptosis, asymmetry) that would benefit from a coordinated reconstructive plan. In these cases, the breast surgical oncologist and the plastic surgeon plan the operation together. The cancer team prioritizes margins and nodal staging. The reconstructive team maps how to close the defect, where to recruit tissue from, and whether the contralateral breast needs a parallel procedure to maintain symmetry. Operating in parallel allows a larger tumor to be safely removed without a disfiguring result and preserves the option of breast conservation in patients who might otherwise be steered toward mastectomy.

Immediate Oncoplastic Reconstruction

When immediate oncoplastic reconstruction is indicated, the reconstruction happens in the same operation as the lumpectomy. This timing matters because the tissue has not yet been changed by radiation. Native breast parenchyma is more elastic, the blood supply is intact, and tissue rearrangement behaves predictably.

The reconstructive options fall into two categories. Displacement techniques mobilize and advance adjacent breast tissue into the lumpectomy defect, redistributing the remaining parenchyma to fill the cavity and reshape the breast. Replacement techniques recruit tissue from outside the breast — most commonly local perforator flaps from the lateral chest wall — when there is not enough native parenchyma to redistribute. In both approaches, contralateral symmetry procedures are often performed at the same operation. A breast lift or breast reduction on the unaffected side balances volume and position, which matters because radiation will subsequently change the treated side and a single-sided reconstruction can drift out of alignment over time. In my practice, avoidance of areas outside of the breast is better as those areas, in theory, could be exposed to cancer cells thus requiring them to be radiated as well.

Delayed Reconstruction After Radiation

Adjuvant radiation reduces local recurrence in breast conservation, and that benefit drives its routine use. The cost is a predictable set of changes in the irradiated tissue: progressive microvascular injury, cellular hypoxia, and fibrosis that develops over months to years. A lumpectomy site that looked acceptable at three months can become tethered, retracted, and discolored at three years. When deformity emerges, surgical correction is possible — but it has to be timed correctly.

Operating on irradiated tissue too early produces poor results. The acute inflammatory phase of radiation needs to resolve and the tissue needs to biologically calm before reconstruction is attempted. In most patients this means a minimum of six to twelve months after the completion of radiation therapy, often longer, and the threshold is clinical rather than calendar-based. Operating before the tissue is ready raises the risk of wound healing problems, fat necrosis, and unsatisfactory results.

The radiation question shapes oncoplastic decision-making in a way I have addressed in published research. As co-author of a systematic review of complications associated with autologous breast reconstruction before and after exposure to radiotherapy (Annals of Surgical Oncology, 2014), I helped evaluate whether timing of radiation relative to reconstruction affects outcomes. The companion review on implant-based reconstruction in the same setting found reconstruction failure rates approaching 20% in irradiated patients. These data inform how I counsel oncoplastic patients about the realistic expectations for revision surgery in irradiated tissue and why the durable reconstructive options in heavily irradiated patients lean toward autologous tissue rather than prosthetic solutions.

Autologous Fat Grafting in the Irradiated Breast

For most patients with established post-radiation deformity, autologous fat grafting is the workhorse of correction. The technique extends beyond simple volume restoration. Adipose tissue is harvested by low-pressure liposuction from a donor site — typically the abdomen or flanks — purified, and injected in microscopic aliquots into the subcutaneous and parenchymal layers of the irradiated breast.

What makes fat grafting particularly useful in this population is the regenerative biology of the graft itself. Adipose-derived stem cells and stromal vascular fraction components within the injected fat promote new blood vessel formation and modulate the local fibrotic response. In practice, this means that fat grafting does more than fill a contour deficit. It softens contracted tissue, improves the quality of the overlying skin, and brings a measure of vascular health back into a field that has been depleted by radiation. Severe deformities typically require sequential, low-volume sessions spaced months apart — partly because the irradiated bed cannot reliably support large-volume single grafts, and partly because the regenerative effect on the tissue compounds over time.

What This Means for Patients

Oncoplastic reconstruction is not one operation. It is a category of approaches matched to a patient's tumor, breast anatomy, radiation plan, and goals. Some patients benefit from immediate tissue rearrangement at the time of lumpectomy. Others are best served by independent lumpectomy with plastic surgery consultation reserved for revision. Many patients with established post-radiation deformity find that staged fat grafting produces a meaningfully better result than they had been told to expect. The right path is determined by the cancer plan, the breast itself, and the timing of radiation — not by a one-size-fits-all algorithm.

‍

Frequently Asked Questions

What is oncoplastic breast reconstruction?

Oncoplastic breast reconstruction integrates lumpectomy with plastic surgery techniques to prevent or correct breast deformity from breast conservation therapy. It can be performed at the same time as cancer surgery (immediate) or later to correct a deformity that develops after radiation (delayed). The goal is to preserve oncologic safety while maintaining the natural appearance of the breast.

When is oncoplastic surgery performed at the same time as a lumpectomy?

Immediate oncoplastic surgery is most useful when the predicted defect is large relative to the breast, when the tumor is in a cosmetically demanding location, or when the patient has features such as macromastia or ptosis that benefit from a coordinated reconstructive plan. For small tumors with favorable breast volume, standard lumpectomy alone is often the right operation.

How long after radiation can I have reconstructive surgery?

Surgical correction of post-radiation breast deformity is usually delayed at least six to twelve months after the completion of radiation. The threshold is clinical rather than calendar-based: tissue must move past the acute inflammatory phase and demonstrate that it has stabilized. Operating on irradiated tissue too early raises the risk of wound healing problems and unsatisfactory results.

Can fat grafting really improve radiation damage?

Fat grafting can meaningfully improve post-radiation deformity. Beyond filling contour deficits, the adipose-derived cells in the grafted fat promote new blood vessel formation and modulate fibrosis. Most patients with significant deformity require multiple low-volume sessions spaced over months. Results vary with the severity of radiation damage and individual healing.

Will I need surgery on the other breast for symmetry?

Often, yes. Contralateral symmetry procedures — a breast lift, reduction, or augmentation on the unaffected side — are commonly performed during oncoplastic reconstruction to balance volume and position. Federal law (Women's Health and Cancer Rights Act of 1998) generally requires insurance coverage for symmetry procedures performed in connection with breast cancer reconstruction.

‍

Medical References

1. Kelley BP, Ahmed R, Kidwell KM, Kozlow JH, Chung KC, Momoh AO. A systematic review of morbidity associated with autologous breast reconstruction before and after exposure to radiotherapy: are current practices ideal? Annals of Surgical Oncology. 2014;21(5):1732–1738. doi: 10.1245/s10434-014-3494-z. PMID: 24473643.
2. Momoh AO, Ahmed R, Kelley BP, Aliu O, Kidwell KM, Kozlow JH, Chung KC. A systematic review of complications of implant-based breast reconstruction with prereconstruction and postreconstruction radiotherapy. Annals of Surgical Oncology. 2014;21(1):118–124. doi: 10.1245/s10434-013-3284-z. PMID: 24081801.
3. Kelley BP, Valero V, Yi M, Kronowitz SJ. Tamoxifen increases the risk of microvascular flap complications in patients undergoing microvascular breast reconstruction. Plastic and Reconstructive Surgery. 2012;129(2):305–314. doi: 10.1097/PRS.0b013e31823ae86c. PMID: 21987043.
4. Schafer HA, Leathers KO, Mumford KC, Ilangovan S, Vetter IL, Henry SL, Kelley BP, Torres-Guzman RA, Egeland BM. "Toward Breast Reinnervation — What is our Endpoint": A systematic review of normal breast sensibility. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2024;91:383–398. PMID: 38461623.
5. American Society of Plastic Surgeons. Breast Reconstruction Options. https://www.plasticsurgery.org/reconstructive-procedures/breast-reconstruction.
6. Dr. Brian P. Kelley faculty profile, Dell Medical School, The University of Texas at Austin; Seton Institute of Reconstructive Plastic Surgery.

‍

Related Topics

• DIEP flap breast reconstruction
  
  • and my Blog Post on DIEP flap breast reconstruction
  • Differences Between DIEP Flap and TRAM Flap
  • DIEP Flap Recovery Guide
• Implants and Implant-based Reconstruction
  
  • Blog Post on Implant-based breast reconstruction
• Post-Mastectomy Breast Sensation
• Autologous Fat Grafting
• Lymphovenous Bypass and Lymphedema Prevention
• Facial and Mohs reconstruction
• Extremity reconstruction and limb salvage
• Lymphovenous Bypass for Post-Mastectomy Lymphedema

Closing Disclaimer

This article is educational and does not establish a doctor-patient relationship. It does not substitute for individualized consultation, examination, or review of personal medical history and oncologic treatment plans. Patients considering oncoplastic breast reconstruction are encouraged to schedule a consultation to discuss their specific situation and reconstructive options.

‍

Written by Brian P. Kelley, MD — Dual Board-Certified Plastic & Hand Surgeon
Medically reviewed: May 3, 2026 · Last updated: May 3, 2026
Educational content. Not a substitute for individualized medical evaluation.